These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8724551)

  • 1. Circadian patterns and triggers of sudden cardiac death.
    Peters RW
    Cardiol Clin; 1996 May; 14(2):185-94. PubMed ID: 8724551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy.
    Behrens S; Ehlers C; Brüggemann T; Ziss W; Dissmann R; Galecka M; Willich SN; Andresen D
    Clin Cardiol; 1997 Mar; 20(3):253-7. PubMed ID: 9068912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death in ischemic heart disease.
    Chang D; Goldstein S
    Compr Ther; 1997 Feb; 23(2):95-103. PubMed ID: 9083719
    [No Abstract]   [Full Text] [Related]  

  • 6. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?
    Uretsky BF; Sheahan RG
    J Am Coll Cardiol; 1997 Dec; 30(7):1589-97. PubMed ID: 9385881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators.
    Tofler GH; Gebara OC; Mittleman MA; Taylor P; Siegel W; Venditti FJ; Rasmussen CA; Muller JE
    Circulation; 1995 Sep; 92(5):1203-8. PubMed ID: 7648666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of sudden cardiac death.
    Goldberger JJ
    Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prevention of sudden cardiac death: effect of recent clinical trials.
    Goldberger JJ
    Arch Intern Med; 1999 Jun; 159(12):1281-7. PubMed ID: 10386504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of sudden cardiac death: management considerations.
    Domanski MJ
    Curr Opin Cardiol; 2000 Jul; 15(4):304-8. PubMed ID: 11139095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmias: antiadrenergic therapy for the patient with coronary artery disease.
    Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S23-31. PubMed ID: 15965569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia.
    Mohamed U; Gollob MH; Gow RM; Krahn AD
    Heart Rhythm; 2006 Dec; 3(12):1486-9. PubMed ID: 17161793
    [No Abstract]   [Full Text] [Related]  

  • 18. Sudden cardiac death: prevention and treatment.
    Kwok KM; Lee KL; Lau CP; Tse HF
    Hong Kong Med J; 2003 Oct; 9(5):357-62. PubMed ID: 14530531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic implantable cardioverter defibrillator therapy in high-risk patients with coronary artery disease.
    Kolettis TM; Saksena S
    Am Heart J; 1994 Apr; 127(4 Pt 2):1164-70. PubMed ID: 7909188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.